Literature DB >> 7540133

A change in gating mode leading to increased intrinsic Cl- channel activity compensates for defective processing in a cystic fibrosis mutant corresponding to a mild form of the disease.

G Champigny1, J L Imler, E Puchelle, W Dalemans, V Gribkoff, J Hinnrasky, K Dott, P Barbry, A Pavirani, M Lazdunski.   

Abstract

The effects of the mild cystic fibrosis (CF) mutation P574H were analysed and compared with those of three severe ones (delta I507, delta F508 and R560T). Immunochemical and functional analyses indicate that the rank order of CFTR expression at the cell surface is: wild type CFTR > P574H >> delta F508 >> R560T approximately 0. Patch-clamp analysis indicates that the open probability of P574H Cl- channels is almost twice as high as that of the wild type CFTR-Cl- channel. This increased intrinsic activity of individual P574H CFTR-Cl- channels compensates for the lower number of P574H CFTR-Cl- channels reaching the cell surface, and probably explains the milder form of CF associated with the P574H mutation. NS004, a recently described activator, restores near normal CFTR activity in cells expressing the P574H-CFTR channel. The P574H mutation modifies the gating mode of the channel with a large increase (approximately x 7) in the mean channel open time. Proline 574 might play an important role in the process connecting ATP hydrolysis at the nucleotide binding domain and opening and closing events of the CFTR-Cl- channel.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7540133      PMCID: PMC398355          DOI: 10.1002/j.1460-2075.1995.tb07239.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  29 in total

1.  Cystic fibrosis and congenital absence of the vas deferens.

Authors:  J M Rigot; J J Lafitte; V Dumur; R Gervais; S Manouvrier; J Biserte; E Mazeman; P Roussel
Journal:  N Engl J Med       Date:  1991-07-04       Impact factor: 91.245

2.  Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis.

Authors:  S H Cheng; R J Gregory; J Marshall; S Paul; D W Souza; G A White; C R O'Riordan; A E Smith
Journal:  Cell       Date:  1990-11-16       Impact factor: 41.582

3.  Identification of the cystic fibrosis gene: genetic analysis.

Authors:  B Kerem; J M Rommens; J A Buchanan; D Markiewicz; T K Cox; A Chakravarti; M Buchwald; L C Tsui
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

Review 4.  Cystic fibrosis: a disease in electrolyte transport.

Authors:  P M Quinton
Journal:  FASEB J       Date:  1990-07       Impact factor: 5.191

5.  Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches.

Authors:  O P Hamill; A Marty; E Neher; B Sakmann; F J Sigworth
Journal:  Pflugers Arch       Date:  1981-08       Impact factor: 3.657

6.  Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA.

Authors:  J R Riordan; J M Rommens; B Kerem; N Alon; R Rozmahel; Z Grzelczak; J Zielenski; S Lok; N Plavsic; J L Chou
Journal:  Science       Date:  1989-09-08       Impact factor: 47.728

7.  A simple assay for agonist-regulated Cl and K conductances in salt-secreting epithelial cells.

Authors:  C J Venglarik; R J Bridges; R A Frizzell
Journal:  Am J Physiol       Date:  1990-08

Review 8.  Vaccinia virus: a tool for research and vaccine development.

Authors:  B Moss
Journal:  Science       Date:  1991-06-21       Impact factor: 47.728

9.  Phosphorylation-regulated Cl- channel in CHO cells stably expressing the cystic fibrosis gene.

Authors:  J A Tabcharani; X B Chang; J R Riordan; J W Hanrahan
Journal:  Nature       Date:  1991-08-15       Impact factor: 49.962

10.  Coupling of CFTR Cl- channel gating to an ATP hydrolysis cycle.

Authors:  T Baukrowitz; T C Hwang; A C Nairn; D C Gadsby
Journal:  Neuron       Date:  1994-03       Impact factor: 17.173

View more
  11 in total

1.  Resveratrol rescues cAMP-dependent anionic transport in the cystic fibrosis pancreatic cell line CFPAC1.

Authors:  Nabila Hamdaoui; Maryvonne Baudoin-Legros; Mairead Kelly; Abdel Aissat; Sandra Moriceau; Diane-Lore Vieu; Julien Colas; Janine Fritsch; Aleksander Edelman; Gabrielle Planelles
Journal:  Br J Pharmacol       Date:  2011-06       Impact factor: 8.739

Review 2.  Cystic fibrosis: channel, catalytic, and folding properties of the CFTR protein.

Authors:  F S Seibert; T W Loo; D M Clarke; J R Riordan
Journal:  J Bioenerg Biomembr       Date:  1997-10       Impact factor: 2.945

3.  Revertant mutants G550E and 4RK rescue cystic fibrosis mutants in the first nucleotide-binding domain of CFTR by different mechanisms.

Authors:  Mónica Roxo-Rosa; Zhe Xu; André Schmidt; Mário Neto; Zhiwei Cai; Cláudio M Soares; David N Sheppard; Margarida D Amaral
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-10       Impact factor: 11.205

4.  CFTR and differentiation markers expression in non-CF and delta F 508 homozygous CF nasal epithelium.

Authors:  F Dupuit; N Kälin; S Brézillon; J Hinnrasky; B Tümmler; E Puchelle
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

5.  Piperacillin-induced immune hemolytic anemia in an adult with cystic fibrosis.

Authors:  Mahesh Bandara; David B Seder; George Garratty; Regina M Leger; Jonathan B Zuckerman
Journal:  Case Rep Med       Date:  2010-06-02

Review 6.  The need for new approaches in CNS drug discovery: Why drugs have failed, and what can be done to improve outcomes.

Authors:  Valentin K Gribkoff; Leonard K Kaczmarek
Journal:  Neuropharmacology       Date:  2016-03-12       Impact factor: 5.250

7.  Comparative pharmacology of the activity of wild-type and G551D mutated CFTR chloride channel: effect of the benzimidazolone derivative NS004.

Authors:  R Dérand; L Bulteau-Pignoux; F Becq
Journal:  J Membr Biol       Date:  2003-07-15       Impact factor: 1.843

8.  Assessing the Disease-Liability of Mutations in CFTR.

Authors:  Claude Ferec; Garry R Cutting
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

9.  A synthetic prostone activates apical chloride channels in A6 epithelial cells.

Authors:  Hui Fang Bao; Lian Liu; Julie Self; Billie Jeanne Duke; Ryuji Ueno; Douglas C Eaton
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-05-29       Impact factor: 4.052

10.  Bicarbonate and chloride secretion in Calu-3 human airway epithelial cells.

Authors:  D C Devor; A K Singh; L C Lambert; A DeLuca; R A Frizzell; R J Bridges
Journal:  J Gen Physiol       Date:  1999-05       Impact factor: 4.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.